Abstract
We assess the frequency of periprocedural ischemic complications associated with balloon-assisted coil embolization (BACE) of unruptured cerebral aneurysms and investigate possible risk factors during BACE. Sixty-one aneurysms of 58 patients were included. Thirty-one aneurysms were treated with BACE and 22 aneurysms were treated with conventional coil embolization (CE). No symptomatic ischemic complications were detected in any of the procedures. Asymptomatic ischemic complications were detected in 14 cases of the BACE group (35.5%) and 11 cases of the CE group (50%) on diffusion weighted MRI (DWI), and there was no significant difference.
These results indicate that BACE is a safe and efficient technique for cerebral aneurysms.
